Adam Grippin

Adam Grippin is a medical professional with a diverse background in research and clinical practice. He served as the Executive Director of the Equal Access Clinic Network at the University of Florida from January 2017 to May 2019.1 In this role, he made significant contributions to the clinic's operations and research initiatives.

Professional Background

Adam Grippin is currently a Radiation Oncology Resident at the University of Texas MD Anderson Cancer Center, where he is investigating immunotherapy.1 He completed his MD/PhD at the University of Florida, focusing on developing a versatile mRNA-nanoparticle platform for stimulating anti-tumor immune responses and predicting treatment outcomes.1

Accomplishments at Equal Access Clinic Network

As Executive Director, Adam Grippin:

1. Obtained IRB approval for collecting and analyzing clinic data
2. Established a Research and Quality Improvement team
3. Collaborated with non-medical departments to systematize research initiatives
4. Increased research dissemination1

Prior to his role as Executive Director, Grippin served as the Physician Recruitment Director for the same organization from May 2014 to January 2017. In this position, he successfully eliminated clinic closures due to lack of attending physicians, a significant improvement from 24 closures in 2014 to zero in 2016.1

Research and Academic Achievements

Adam Grippin has made notable contributions to cancer research:

• Engineered an mRNA-nanoparticle platform for use as a personalized tumor vaccine
• Designed pre-clinical studies leading to FDA approval for a first-in-human clinical trial
• Applied for global patent protection on his technology
• Presented work at national and international conferences
• Earned $470,000 in grant funding
• Published results as first author in ACS Nano and second author in NanoLetters1

Awards and Recognitions

Throughout his career, Adam Grippin has received several awards, including:

• Ruth L. Kirschstein National Research Service Award (2018)
• Best Poster Award in the Therapeutic Vaccination category at CIMT Annual Meeting (2018)
• Best Oral Presentation at University of Florida Biomaterials Day (2018 and 2019)1

Adam Grippin's LinkedIn profile username is indeed adam-grippin, as mentioned in the query.1